Silver (XAG/USD) gains traction on Wednesday as renewed optimism surrounding a potential US-Iran peace deal triggers a sharp decline in the US Dollar (USD) and Oil prices. At the time of writing, XAG/USD is trading around 77, up over 5.50% on the day
Analysts cite reduced expectations for margin expansion as CDW faces cost pressures and slower growth prospects. Raymond James reduced its price target for CDW shares after reassessing the company’s operating leverage outlook. The adjustment reflects concerns over margin e
The Investing.com United Kingdom 100 index rose sharply amid broad-based gains in London equities. The Investing.com United Kingdom 100 index closed 2.13% higher, reflecting a strong performance across UK equities. Gains were driven by investor optimism following recent ec
Spain’s benchmark stock index climbs on broad-based gains, marking its strongest session in over a month. Spanish stocks ended the session sharply higher, with the IBEX 35 index advancing 2.47% to close at its highest level since early August. The rally was driven by gains
Investors await Harmony Bio’s Q1 results amid concerns over margin contraction following a weaker-than-expected Q4 performance. Harmony Bio is set to report first-quarter earnings, with analysts closely watching for signs of margin recovery. The company’s Q4 results fell s
Precious metals surge on inflation concerns, central bank demand, and expectations of Federal Reserve rate cuts. Gold prices rose above $4,710, marking a 3.4% gain, while silver jumped 6.4% to $77.46 as the precious metals rally accelerated. The moves reflect growing inves
DraftKings expected to show Q1 growth DraftKings is anticipated to report Q1 earnings growth. The company's performance is being closely watched by investors. The earnings preview comes as estimate revisions signal caution. This may impact investor expectations for th
First-quarter results for S&P 500 firms surpass forecasts despite macroeconomic uncertainty and market turbulence. S&P 500 companies have delivered stronger-than-expected earnings in the first quarter, defying broader market volatility and economic concerns. Aggregate prof
Is this your perfect match? 🔥 Our review explores Versus Trade’s low spreads, high leverage up to 2000:1, and rare asset pairs like Bitcoin vs Gold. But it’s not all perfect...Find out the limitations before you decide. 👉 Dive into the full review here! https://fxstreet.pa
Investors await Akebia's Q1 2026 financial results, focusing on revenue trends and operational performance in the biopharmaceutical sector. Akebia is scheduled to release its Q1 2026 earnings, with analysts closely monitoring revenue figures and pipeline developments. The
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.